Mice with Established Diabetes Show Increased Susceptibility to Renal Ischemia/Reperfusion Injury Protection by Blockade of Jnk or Syk Signaling Pathways

Patients with diabetes are at an increased risk for acute kidney injury (AKI) after renal ischemia/ reperfusion injury (IRI). However, there is a lack preclinical models of IRI in established diabetes. The current study characterized renal IRI in mice with established diabetes and investigated potential therapies. Diabetes was induced in C57BL/6J mice by low-dose streptozotocin injection. After 7 weeks of sustained diabetes, mice underwent 13 minutes of bilateral renal ischemia and were euthanized after 24 hours of reperfusion. Age-matched, nondiabetic controls underwent the same surgical procedure. Renal IRI induced two-and sevenfold increases in plasma creatinine level in nondiabetic and diabetic mice, respectively (P < 0.001). Kidney damage, as indicated by histologic damage, tubular cell death, tubular damage markers, and inflammation, was more severe in the diabetic IRI group. The diabetic IRI group showed greater accumulation of spleen tyrosine kinase (Syk)-expressing cells, and increased c Jun N-terminal kinase (Jnk) signaling in tubules compared to nondiabetic IRI. Prophylactic treatment with a Jnk or Syk inhibitor substantially reduced the severity of AKI in the diabetic IRI model, with differential effects on neutrophil infiltration and Jnk activation. In conclusion, established diabetes predisposed mice to renal IRI-induced AKI. Two distinct proinflammatory pathways, JNK and SYK, were identified as potential therapeutic targets for anticipated AKI in patients with diabetes. (Am J Pathol 2022, 192: 441-453; https://doi.org/10.1016/j.ajpath.2021.12.003)

Automated summary

This study found that mice with established diabetes were more susceptible to acute kidney injury (AKI) associated with renal ischemia/reperfusion injury (IRI). The researchers identified JNK and SYK as potential therapeutic targets for anticipated AKI in patients with diabetes.